Dr. Reddy's Laboratories Limited RDY reported third-quarter fiscal 2025 earnings of 20 cents per American Depositary Share ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

Sandoz Group AG (SDZNY), a Swiss generic and biosimilar medicines maker, Tuesday announced that the global generics and biosimilars ...

Medicare can help cover the cost of your Adderall prescription or a generic version. You can get coverage using a Medicare Part D or a Medicare Advantage (Part C) plan. Adderall is a commonly ...

Teva cannot market its generic version of Firdapse in the U.S. before February 25, 2035, unless specific conditions arise. Ongoing Firdapse patent litigation continues against Hetero and Lupin ...

Formula 1 has extended its contract with the Belgian Grand Prix but one of the sport’s most established races is set to be dropped from the schedule in 2028 and 2030.

Aetna alleges generic drugmakers colluded to inflate prices of essential medications, with increases reaching as high as 2,762%. The lawsuit claims a "fair share" market allocation system and ...

While much of the world ushers in the new year on January 1 following the Gregorian calendar, many countries and cultures celebrate the start of their new year on different dates, reflecting their ...

December 23, 2024, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor ...

Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...